SMURF1-Interference Effects Autophagy and Pulmonary Fibrosis through SMAD7 and the TGF-β1/SMAD Pathway

Chanda D., Otoupalova E., Smith S.R., Volckaert T., De Langhe S. P., Thannickal V.J. 2019. Developmental pathways in the pathogenesis of lung fibrosis. Mol. Aspects Med. 65, 56–69.

Article  CAS  PubMed  Google Scholar 

Hu H.H., Chen D.Q., Wang Y.N., Feng Y.L., Cao G., Vaziri N.D., Zhao Y.Y. 2018. New insights into TGF-β/Smad signaling in tissue fibrosis. Chem. Biol. Interact. 292, 76–83.

Article  CAS  PubMed  Google Scholar 

Hata A., Lagna G., Massagué J., Hemmati-Brivanlou A. 1998. Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev. 12, 186–197.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hayashi H., Abdollah S., Qiu Y., Cai J., Xu Y.Y., Grinnell B.W., Richardson M.A., Topper J.N., Gimbrone M.A., Jr, Wrana J.L., Falb D. 1997. The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell. 89, 1165–1173.

Article  CAS  PubMed  Google Scholar 

Imamura T., Takase M., Nishihara A., Oeda E., Hanai J., Kawabata M., Miyazono K. 1997. Smad6 inhibits signalling by the TGF-beta superfamily. Nature. 389, 622–626.

Article  CAS  PubMed  Google Scholar 

Nakao A., Afrakhte M., Morén A., Nakayama T., Christian J.L., Heuchel R., Itoh S., Kawabata, M., Heldin N.E., Heldin C.H., ten Dijke P. 1997. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature. 389, 631–635.

Article  CAS  PubMed  Google Scholar 

Su D.N., Wu S.P., Xu S.Z. 2020. Mesenchymal stem cell-based Smad7 gene therapy for experimental liver cirrhosis. Stem Cell Res. Ther. 11, 395.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li X.F., Zhang S.H., Liu G.F., Yu S.N. 2022. miR-363 alleviates detrusor fibrosis via the TGF-β1/Smad signaling pathway by targeting Col1a2 in rat models of STZ-induced T2DM. Mol. Ther. Nucleic Acids. 29, 1142–1153.

Article  CAS  Google Scholar 

Nagarajan R.P., Zhang J., Li W., Chen Y. 1999. Regulation of Smad7 promoter by direct association with Smad3 and Smad4. J. Biol. Chem. 274, 33412–33418.

Article  CAS  PubMed  Google Scholar 

Yan X., Liao H., Cheng M., Shi X., Lin X., Feng X.H., Chen Y.G. 2016. Smad7 protein interacts with receptor-regulated Smads (R-Smads) to inhibit transforming growth factor-β (TGF-β)/Smad signaling. J. Biol. Chem. 291, 382–392.

Article  CAS  PubMed  Google Scholar 

Meng L., Zhang X., Wang H., Dong H., Gu X., Yu X., Liu Y. 2019. Yangyin Yiqi Mixture ameliorates bleomycin-induced pulmonary fibrosis in rats through inhibiting TGF-β1/Smad pathway and epithelial to mesenchymal transition. Evidence-Based Complementary Altern. Med. 2019, 2710509.

Article  Google Scholar 

Gao C., Chang H., Wang Z., Jia M., Li Q., Li X., Shi S., Bu H. 2023. The mechanism of Qingwen Gupi decoction on pulmonary fibrosis based on metabolomics and intestinal flora. J. Appl. Microbial. 134, lxac035.

Huang S., Li Y., Wu P., Xiao Y., Duan N., Quan J., Du W. 2020. microRNA-148a-3p in extracellular vesicles derived from bone marrow mesenchymal stem cells suppresses SMURF1 to prevent osteonecrosis of femoral head. J. Cell. Mol. Med. 24, 11512–11523.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gifford C.C., Tang J., Costello A., Khakoo N.S., Nguyen T.Q., Goldschmeding R., Higgins P. J., Samarakoon R. 2021. Negative regulators of TGF-β1 signaling in renal fibrosis; pathological mechanisms and novel therapeutic opportunities. Clin. Sci. (London). 135, 275–303.

Article  CAS  Google Scholar 

Kim M.S., Baek A.R., Lee J.H., Jang A.S., Kim D.J., Chin S.S., Park S.W. 2019. IL-37 attenuates lung fibrosis by inducing autophagy and regulating TGF-β1 production in mice. J. Immunol. (Baltimore). 203, 2265–2275.

Article  CAS  PubMed  Google Scholar 

Liu M.W., Su M.X., Tang D.Y., Hao L., Xun X.H., Huang Y.Q. 2019. Ligustrazin increases lung cell autophagy and ameliorates paraquat-induced pulmonary fibrosis by inhibiting PI3K/Akt/mTOR and hedgehog signalling via increasing miR-193a expression. BMC Pulm. Med. 19, 35.

Article  PubMed  PubMed Central  Google Scholar 

Baek A.R., Hong J., Song K.S., Jang A.S., Kim D.J., Chin S.S., Park S.W. 2020. Spermidine attenuates bleomycin-induced lung fibrosis by inducing autophagy and inhibiting endoplasmic reticulum stress (ERS)-induced cell death in mice. Exp. Mol. Med. 52, 2034–2045.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chitra P., Saiprasad G., Manikandan R., Sudhandiran G. 2015. Berberine inhibits Smad and non-Smad signaling cascades and enhances autophagy against pulmonary fibrosis. J. Mol. Med. (Berl.). 93, 1015–1031.

Article  CAS  PubMed  Google Scholar 

d’Alessandro M., Conticini E., Bergantini L., Cameli P., Cantarini L., Frediani B., Bargagli E. 2022. Neutrophil extracellular traps in ANCA-associated vasculitis and interstitial lung disease: A scoping review. Life (Basel). 12 (2), 317.

Article  PubMed  PubMed Central  Google Scholar 

Saleh M., Fotook Kiaei S.Z., Kavianpour M. 2022. Application of Wharton jelly-derived mesenchymal stem cells in patients with pulmonary fibrosis. Stem Cell Res. Ther. 13, 71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sapkota G., Alarcón C., Spagnoli F.M., Brivanlou A.H., Massagué J. 2007. Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol. Cell. 25, 441–454.

Article  CAS  PubMed  Google Scholar 

Song M.K., Lee J.H., Ryoo I.G., Lee S.H., Ku S.K., Kwak M.K. 2019. Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation. Free Radical Biol. Med. 138, 33–42.

Article  CAS  Google Scholar 

Li S.X., Li C., Pang X.R., Zhang J., Yu G.C., Yeo A.J., Lavin M.F., Shao H., Jia Q., Peng C. 2021. Metformin attenuates silica-induced pulmonary fibrosis by activating autophagy via the AMPK-mTOR signaling pathway. Front. Pharmacol. 12, 719589.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu Y., Zhong W., Liu Y., Chen W., Zhang J., Zeng Z., Huang H., Qiao Y., Wan X., Meng X., Cai S., Dong H. 2022. Anti-PD-L1 antibody alleviates pulmonary fibrosis by inducing autophagy via inhibition of the PI3K/Akt/mTOR pathway. Int. Immunopharmacol. 104, 108504.

Article  CAS  PubMed  Google Scholar 

Lv X., Li K., Hu Z. 2020. Autophagy and pulmonary fibrosis. Adv. Exp. Med. Biol. 1207, 569–579.

Article  CAS  PubMed  Google Scholar 

Mizushima N., Komatsu M. 2011. Autophagy: Renovation of cells and tissues. Cell. 147, 728–741.

Article  CAS  PubMed  Google Scholar 

Murphy G., Cockett M.I., Ward R.V., Docherty A.J. 1991. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). Biochem. J. 277 (Pt 1), 277–279.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sires U.I., Murphy G., Baragi V.M., Fliszar C.J., Welgus H.G., Senior R.M. 1994. Matrilysin is much more efficient than other matrix metalloproteinases in the proteolytic inactivation of alpha 1-antitrypsin. Biochem. Biophys. Res. Commun. 204, 613–620.

Article  CAS  PubMed  Google Scholar 

Zheng C.M., Lu K.C., Chen Y.J., Li C.Y., Lee Y.H., Chiu H.W. 2022. Matrix metalloproteinase-7 promotes chronic kidney disease progression via the induction of inflammasomes and the suppression of autophagy. Biomed. Pharmacother. 154, 113565.

Article  CAS  PubMed  Google Scholar 

留言 (0)

沒有登入
gif